Angus Grant is EVP, Business Development of TEVA PHARMACEUTICAL INDUSTRIES LTD. Currently has a direct ownership of 8,848 shares of TEVA, which is worth approximately $154,840. The most recent transaction as insider was on Aug 09, 2024, when has been sold 4,065 shares (Ordinary Shares) at a price of $17.28 per share, resulting in proceeds of $70,243. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.85K
n/a 3M change
n/a 12M change
Total Value Held $154,840

Angus Grant Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 09 2024
SELL
Open market or private sale
$70,243 $17.28 p/Share
4,065 Reduced 31.48%
8,848 Ordinary Shares
Aug 09 2024
BUY
Exercise of conversion of derivative security
-
12,913 Added 50.0%
12,913 Ordinary Shares
AG

Angus Grant

EVP, Business Development
Tel Aviv, L3

Track Institutional and Insider Activities on TEVA

Follow TEVA PHARMACEUTICAL INDUSTRIES LTD and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TEVA shares.

Notify only if

Insider Trading

Get notified when an Teva Pharmaceutical Industries LTD insider buys or sells TEVA shares.

Notify only if

News

Receive news related to TEVA PHARMACEUTICAL INDUSTRIES LTD

Track Activities on TEVA